000 | 00995 a2200289 4500 | ||
---|---|---|---|
005 | 20250516204742.0 | ||
264 | 0 | _c20140527 | |
008 | 201405s 0 0 eng d | ||
022 | _a1572-0241 | ||
024 | 7 |
_a10.1038/ajg.2013.482 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPraveen, Sharma | |
245 | 0 | 0 |
_aResponse to Congly and Leise. _h[electronic resource] |
260 |
_bThe American journal of gastroenterology _cApr 2014 |
||
300 |
_a598-9 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
650 | 0 | 4 |
_aHepatic Encephalopathy _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLactulose _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aRifamycins _xtherapeutic use |
700 | 1 | _aChander, Sharma Barjesh | |
773 | 0 |
_tThe American journal of gastroenterology _gvol. 109 _gno. 4 _gp. 598-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2013.482 _zAvailable from publisher's website |
999 |
_c23705190 _d23705190 |